2016年-数据局_贝恩：BAIN_REPORT_Global_Healthcare_Private_Equity_2016_40页_1mb

2016 Global Healthcare Private Equity and Corporate M&A Report Summary

Core Content of the Report

This report, published by Bain & Company in 2016, provides an in-depth analysis of the healthcare private equity (PE) and corporate M&A landscape in 2015. It highlights the trends, challenges, and opportunities in the sector, emphasizing the role of PE firms and corporate buyers in shaping the industry's future. The report is structured around several key sections, including an overview of M&A trends, implications for both corporate and PE buyers, a review of 2015 PE activity, geographic and sector trends, and insights into exit strategies and future outlook.

Main Points and Key Information

Corporate M&A Trends in 2015

• Record-breaking deal value: Healthcare M&A reached $546 billion in 2015, a 2.5 times increase compared to the previous decade's average.
• Corporate dominance: Corporate buyers accounted for the majority of healthcare M&A activity, with $523 billion in deal value.
• Megamergers: Five deals over $20 billion were announced, representing a third of the total deal value.
• Category leadership: The pursuit of category leadership was a major driver of M&A, with companies like Shire and Dentsply Sirona making significant acquisitions to strengthen their positions.
• Macro trends: Weak economic growth, access to cheap debt, and the desire to consolidate in response to cost pressures and regulatory changes fueled M&A activity.
• Tax inversions: These were a financial incentive for some deals, though regulatory changes have reduced their appeal.

Implications for Corporate Buyers

• Leadership strategy: Corporate buyers should focus on category leadership to maintain vendor relationships and invest during downturns.
• Deal alignment: Align acquisitions with strategic goals and conduct thorough due diligence to ensure they support long-term value.
• M&A capability: Building a repeatable M&A capability is crucial for success, including identifying the right deals, tailoring integration, and learning from past missteps.
• Simplification: Streamlining operations and reducing complexity can unlock growth.
• Creative deal structures: Asset swaps and partnerships with PE firms are becoming more common, enabling access to specialized assets and expertise.

Implications for Private Equity Buyers

• Activity across deal sizes: PE firms were active in all healthcare deal sizes, including the “sweet spot” of $500 million to $5 billion.
• Decline in deal value: While deal volume increased by 6%, total deal value decreased by 20% in 2015, with more focus on strategic acquisitions rather than volume.
• Category leadership: PE buyers continued to seek category leaders, often paying a premium for these assets, which have proven to deliver strong returns.
• Buy-and-build strategy: Investors used this approach to acquire platform companies and build market leadership through consolidation.
• Exit opportunities: PE funds saw strong exit activity in 2015, with a rise in sponsor-to-sponsor and sponsor-to-corporate sales, though IPO activity declined.

Private Equity 2015 in Review

• Strong year for PE: 2015 was a record year for PE investments and exits, with 199 deals and 145 exits.
• Sector performance: Provider and related services dominated, accounting for over half of the deal value and five of the top ten deals.
• Geographic activity: Asia-Pacific saw record deal value growth, driven by China and India. North America and Europe also remained active, though deal value declined slightly compared to 2014.
• Investment strategies: PE investors continued to pursue both healthcare-light and healthcare-heavy assets, with a growing comfort in managing reimbursement risks.

Sector Trends

• Provider and related services: This sector saw the most investment, with strong activity in HCIT, retail health, and European labs.
• Biopharma and related services: Significant investment in outsourced services and generics, though some activity declined due to large carve-outs.
• Medtech and related services: Investor interest in diagnostics and outsourced services remained strong, despite a decline in overall investment.
• Payer and related services: Activity was lower in 2015 compared to 2014 due to consolidation among major payers.

Exit Activity

• Record exits: 2015 was a strong year for exits, with a rise in both sponsor-to-sponsor and sponsor-to-corporate transactions.
• IPO decline: The reduction in IPO activity opened new opportunities for PE funds to exit through other channels.
• Strategic exits: PE firms focused on securing assets that could be sold to corporate buyers, especially those that had been destined for an IPO.

2016 and Beyond Outlook

• Macro uncertainty: The report anticipates continued macroeconomic uncertainty and the possibility of a global recession.
• Opportunities for PE: A shift in deal-making conditions may present opportunities for PE investors who are prepared, including lower asset values and more PE-friendly exits.
• Strategic focus: Investors who excel in identifying the best assets, addressing portfolio vulnerabilities, and using creative deal structures will be more successful.

Conclusion

The report underscores that healthcare remains a critical sector for PE investment, despite macroeconomic headwinds. It highlights the importance of category leadership, strategic M&A, and creative deal-making in navigating the evolving market. With a focus on long-term fundamentals, the healthcare sector is expected to continue being a key area for investment and growth in the years ahead.